Published in Medicine (Baltimore) on September 01, 1997
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis (2012) 2.21
Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies. Ann Rheum Dis (2004) 1.15
Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases. Arthritis Res Ther (2009) 1.05
Lupus vasculopathy combined with acute renal failure in lupus nephritis. Pediatr Nephrol (2003) 0.82
Pathological spectrums and renal prognosis of severe lupus patients with rapidly progressive glomerulonephritis. Rheumatol Int (2014) 0.79
Evaluation of clinical outcomes and renal vascular pathology among patients with lupus. Clin J Am Soc Nephrol (2012) 0.79
Renal Interstitial Arteriosclerotic Lesions in Lupus Nephritis Patients: A Cohort Study from China. PLoS One (2015) 0.78
Rapidly progressive lupus nephritis and concomitant thrombotic microangiopathy. Clin Exp Nephrol (2010) 0.77
Clinicopathologic correlations of renal microthrombosis and inflammatory markers in proliferative lupus nephritis. Arthritis Res Ther (2012) 0.77
Association of miRNA-145 expression in vascular smooth muscle cells with vascular damages in patients with lupus nephritis. Int J Clin Exp Pathol (2015) 0.75
Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER). Medicine (Baltimore) (2016) 0.75
Bilateral renal infarction in a lupus patient: an unusual pathology. Clin Med Insights Case Rep (2013) 0.75
A girl with difficult lupus nephritis: lupus vasculopathy. Clin Exp Nephrol (2012) 0.75
Efficacy of Intravenous Cyclophosphamide Pulse Therapy for P-Glycoprotein-expressing B Cell-associated Active True Renal Lupus Vasculitis in Lupus Nephritis. Intern Med (2017) 0.75
Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int (1998) 4.31
A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. Arthritis Rheum (1997) 3.62
Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest (2000) 3.60
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11
Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet (1997) 2.38
Anti-glomerular-basement-membrane disease after lithotripsy. Lancet (1990) 2.11
Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant (2001) 1.90
The value of indirect immunofluorescence and solid phase techniques for ANCA detection. A report on the first phase of an international cooperative study on the standardization of ANCA assays. EEC/BCR Group for ANCA Assay Standardization. J Immunol Methods (1993) 1.86
Increased plasma serotonin in primary pulmonary hypertension. Am J Med (1995) 1.86
Antineutrophil cytoplasm antibodies in systemic polyarteritis nodosa with and without hepatitis B virus infection and Churg-Strauss syndrome--62 patients. J Rheumatol (1993) 1.86
Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies. Kidney Int (2006) 1.74
Inefficacy and toxicity of pefloxacin in focal and segmental glomerulosclerosis with steroid-resistant nephrotic syndrome. Lancet (1993) 1.72
Liver involvement in autosomal-dominant polycystic kidney disease: therapeutic dilemma. J Am Soc Nephrol (2000) 1.66
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension. Nat Med (2002) 1.65
Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int (1993) 1.56
Early renal changes in hemizygous and heterozygous patients with Fabry's disease. Kidney Int (1978) 1.56
H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int (1986) 1.55
Genetic heterogeneity of Alport syndrome. Kidney Int (1985) 1.55
Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation. Br J Haematol (1990) 1.53
Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. Thromb Res (1991) 1.51
Necrotizing crescentic glomerulonephritis without significant immune deposits: a clinical and serological study. Q J Med (1993) 1.48
Renal prognosis in Alport's and related syndromes: influence of the mode of inheritance. Nephrol Dial Transplant (1989) 1.48
Gitelman syndrome comes of age. Nephrol Dial Transplant (1998) 1.47
Embolic and bleeding events after modified Bentall procedure in selected patients. Heart (2006) 1.47
Autosomal dominant polycystic kidney disease with primary hyperaldosteronism. Nephrol Dial Transplant (1992) 1.46
Validation of a live animal model for training in endoscopic hemostasis of upper gastrointestinal bleeding ulcers. Endoscopy (2013) 1.46
Acute renal failure after high doses of gentamicin and cephalothin. Lancet (1973) 1.44
The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol (1999) 1.44
Pulmonary-renal syndrome due to hemorrhagic fever with renal syndrome: an unusual manifestation of puumala virus infection in France. Clin Nephrol (2003) 1.42
Infants with Kasabach-Merritt syndrome do not have "true" hemangiomas. J Pediatr (1997) 1.42
Acute renal failure in pregnancy. Baillieres Clin Obstet Gynaecol (1994) 1.39
Sclerochoroidal calcification associated with Gitelman syndrome. Am J Ophthalmol (1999) 1.38
Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int (2006) 1.37
Charge and size of mesangial IgA in IgA nephropathy. Kidney Int (1985) 1.34
A large subset of neutrophils expressing membrane proteinase 3 is a risk factor for vasculitis and rheumatoid arthritis. J Am Soc Nephrol (1999) 1.34
Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum Mutat (1999) 1.34
The clinical spectrum of hereditary nephritis. Kidney Int (1985) 1.33
A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant (2008) 1.31
Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens (2001) 1.29
European consensus statement on the terminology used in the management of lupus glomerulonephritis. Lupus (2009) 1.28
Diagnostic procedures and long-term prognosis in bilateral renal cortical necrosis. Kidney Int (1973) 1.27
Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett (1995) 1.26
Renal granulomatous sarcoidosis: report of six cases. Nephrol Dial Transplant (1990) 1.26
Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients. Am J Med (1979) 1.25
Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme. J Clin Invest (1980) 1.25
Alport's syndrome: experience at Hôpital Necker. Kidney Int Suppl (1982) 1.25
Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules. Blood (1999) 1.23
Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1992) 1.21
Liver changes and complications in adult polycystic kidney disease. Adv Nephrol Necker Hosp (1985) 1.20
Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet (1996) 1.20
Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum (1982) 1.19
Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome. Clin Lab Haematol (2002) 1.19
Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients. Clin Nephrol (1993) 1.17
Pregnancy in women with impaired renal function. Clin Nephrol (1997) 1.16
Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Cancer Res (1999) 1.16
Monoclonal antibody to human platelet glycoprotein I. II. Effects on human platelet function. Br J Haematol (1981) 1.15
Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome. Am J Hum Genet (1998) 1.13
Renal hemodynamics and segmental tubular reabsorption in early type 1 diabetes. Kidney Int (1990) 1.13
Age and gender-related incidence of chronic renal failure in a French urban area: a prospective epidemiologic study. Nephrol Dial Transplant (1996) 1.12
Autosomal recessive polycystic kidney disease in adulthood. Nephrol Dial Transplant (2001) 1.11
Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis. Clin Immunol Immunopathol (1988) 1.10
Autologous platelet concentrate for the treatment of full-thickness macular holes. Graefes Arch Clin Exp Ophthalmol (1995) 1.09
Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am J Pathol (1997) 1.09
Differential distribution of von Willebrand factor in endothelial cells. Comparison between normal pigs and pigs with von Willebrand disease. Arteriosclerosis (1987) 1.09
Human neutrophils release their major membrane sialoprotein, leukosialin (CD43), during cell activation. Eur J Immunol (1992) 1.09
Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods (1996) 1.08
Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival? J Urol (1996) 1.08
Relationship between the integrity of Bowman's capsule and the composition of cellular crescents in human crescentic glomerulonephritis. Lab Invest (1987) 1.07
Acute renal artery thrombosis associated with factor V Leiden mutation. Nephrol Dial Transplant (1996) 1.07
Primary pulmonary hypertension in a patient with a familial platelet storage pool disease: role of serotonin. Am J Med (1990) 1.07
Impact of inhaled nitric oxide on platelet aggregation and fibrinolysis in rats with endotoxic lung injury. Role of cyclic guanosine 5'-monophosphate. Am J Respir Crit Care Med (1998) 1.07
Hemodialysis-associated amyloidosis and beta-2 microglobulin. Clinical and immunohistochemical study. Am J Med (1987) 1.07
Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis (1998) 1.07
High plasma serotonin levels in primary pulmonary hypertension. Effect of long-term epoprostenol (prostacyclin) therapy. Arterioscler Thromb Vasc Biol (2000) 1.07
Characteristic ultrastructural lesion of the glomerular basement membrane in progressive hereditary nephritis (Alport's syndrome). Lab Invest (1972) 1.07
Characterization of mononuclear cell subsets in renal cellular interstitial infiltrates. Kidney Int (1986) 1.06
Renal prognosis in women with hereditary nephritis. Clin Nephrol (1985) 1.05
Education of human lymphocytes against mouse cells: specific recognition of H-2 antigens. Eur J Immunol (1977) 1.05
Substitution of arginine for glycine 325 in the collagen alpha 5 (IV) chain associated with X-linked Alport syndrome: characterization of the mutation by direct sequencing of PCR-amplified lymphoblast cDNA fragments. Am J Hum Genet (1992) 1.03
A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum. J Immunol Methods (1982) 1.02
Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol (1982) 1.02
Retinoic acid for treatment of multicentric Castleman's disease. Lancet (1999) 1.02
Genetic, clinical, and morphologic heterogeneity in Alport's syndrome. Adv Nephrol Necker Hosp (1993) 1.01
Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study. Rheumatology (Oxford) (2001) 1.00
[Treatment of severe arterial hypertension with captopril (SQ 14.225) (author's transl)]. Nouv Presse Med (1981) 0.99
Acute renal failure in pregnancy: 1987. Am J Kidney Dis (1987) 0.98
The role of circulating immune complexes in the glomerular disease of experimental hepatosplenic schistosomiasis. Clin Exp Immunol (1979) 0.98
Immunologically-mediated acute renal failure of nonglomerular origin in the course of systemic lupus erythematosus [SLE]. Report of two cases. Am J Med (1979) 0.98
Follow-up evaluation of the first patients with IgA nephropathy described at Necker Hospital. Contrib Nephrol (1993) 0.97
Immunohistochemical characterization of renal amyloidosis. Am J Clin Pathol (1987) 0.97
Pregnancy in women with reflux nephropathy. Kidney Int (1996) 0.96